Tropical Diseases

Developing medicines for tropical diseases

60° Pharmaceuticals (60P) was founded with the goal of developing medicines for tropical diseases, including those considered neglected by the World Health Organization. Malaria and dengue fever are on this list, but despite competitive drug development pipelines for these diseases, critical gaps remain.

 

60P is focused on drug development for therapeutic methods left unaddressed by the established research and development networks. In order to improve overall return on investment, 60P will also invest in products for tropical diseases targeted at market segments in industrialized countries.

405,000

Annual deaths from malaria globally

125,000,000

Travelers to endemic regions per annum

390,000,000

Dengue infections per year

202-327-5422

1025 Connecticut Ave. NW, Suite 1000, Washington, DC 20036